CIK 0001213037
- Non-accelerated filer
- Smaller reporting company
Cardiff Oncology, Inc.
Sign in to watch- Ticker
- CRDF
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 272004382
- Phone
- +1 858-952-7570
- Business address
- 11055 FLINTKOTE AVENUE, SAN DIEGO, CA, 92121
- Former names
- Trovagene, Inc., TrovaGene Inc., XENOMICS INC, USED KAR PARTS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 65 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-06-11 | White Lale Director | Grant or award · Stock Options | +40,565 | 199,246 | ||
| 2025-06-26 | White Lale Director | Grant or award · Stock Options | +40,565 | 158,681 | ||
| 2024-06-27 | White Lale Director | Grant or award · Stock Options | +29,700 | 146,974 | ||
| 2023-06-15 | White Lale Director | Grant or award · Stock Options | +27,700 | 117,274 | ||
| 2022-09-19 | White Lale Director | Purchase | +15,000 | $1.64 | $25K | 113,788 |
| 2022-07-05 | White Lale Director | Option exercise | +28,858 | $2.60 | $75K | 98,788 |
| 2022-07-05 | White Lale Director | Option exercise · Stock Options | −28,858 | $2.60 | $75K | 60,716 |
| 2022-03-09 | White Lale Director | Grant or award · Stock Options | +26,800 | 89,574 | ||
| 2021-06-10 | White Lale Director | Grant or award · Stock Options | +22,000 | 62,774 | ||
| 2020-06-17 | White Lale Director | Grant or award · Stock Options | +28,858 | 40,774 | ||
| 2020-05-14 | White Lale Director | Purchase | +69,930 | $1.43 | $100K | 69,930 |
| 2020-04-16 | White Lale Director | Grant or award · Stock Options | +11,916 | 11,916 |
Page 1 of 1 · 12 trades